FAKTOR OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000PN2SYK2

Delayed Deutsche Boerse AG 12:50:51 07/06/2024 pm IST
69.1 EUR -0.16% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month+5.28%
1 month+12.24%
Date Price Change
07/24/07 69.1 -0.16%
06/24/06 69.21 +0.98%
05/24/05 68.54 +2.01%
04/24/04 67.19 +2.17%
03/24/03 65.76 +0.03%

Delayed Quote Deutsche Boerse AG

Last update June 07, 2024 at 12:50 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN2SYK
ISINDE000PN2SYK2
Date issued 21/01/2022
Strike 346 $
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 75.79
Lowest since issue 28.2
Spread 2.81
Spread %3.91%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
349.6 USD
Average target price
373.1 USD
Spread / Average Target
+6.70%
Consensus